Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFXI.L Regulatory News (FXI)

  • There is currently no data for FXI

Director's Share Dealing

5 Feb 2016 14:44

RNS Number : 2749O
Fusionex International PLC
05 February 2016
 

For immediate Release

5 February 2016

 

 

 

Fusionex International plc

("Fusionex" or "the Company")

 

Director's Share Dealing

 

The Company received notification that Alan Lim, Non-Executive Director of Fusionex, acquired 2,000 ordinary shares in the Company ("Ordinary Share") at a price of 135 pence per Ordinary Share on 5 February 2016. Following the purchase, Alan Lim has a beneficial interest of 26,500 Ordinary Shares, 0.06 per cent. of the Company's issued share capital.

 

 

For further details:

 

Fusionex

Ivan Teh, Chief Executive Officer

Yuen Choong Lai, Chief Financial Officer

Darren Hopkins, Director for Investor Relations & Corporate Development

 

Through Buchanan

 

Panmure Gordon

Fred Walsh, Alina Vaskina (Investment Banking)

Erik Anderson, Tom Nicholson, Charles Leigh-Pemberton (Corporate Broking)

 

020 7886 2500

RBC Capital Markets

Pierre Schreuder, Ema Jakasovic

020 7653 4000

 

Buchanan

Sophie McNulty, Gabriella Clinkard, Steph Watson

www.buchanan.uk.com

020 7466 5000

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUVSSRNOAURAR
Date   Source Headline
28th Jan 20169:55 amRNSDirector's Share Dealing
28th Jan 20167:00 amRNSDirector's Share Dealing
26th Jan 201611:43 amRNSDirector's Share Dealing
22nd Jan 20167:30 amRNSStatement in response to share price movement
21st Jan 20167:00 amRNSPreliminary results
18th Jan 20167:00 amRNSMillion dollar Open Data contract win
13th Jan 20167:00 amRNSGIANT contract win with Asian hospital
12th Jan 201610:00 amRNSNotification of Full Year Results
1st Dec 201510:22 amRNSNotification of Major Interest in Shares
1st Dec 20157:00 amRNSGIANT Contract Win
13th Nov 20157:00 amRNSDell & Fusionex Enter Into a GIANT Partnership
15th Oct 20157:01 amRNSPlacing
15th Oct 20157:00 amRNSTrading Update
29th Sep 20154:31 pmRNSTransfer of Shares
24th Jun 20157:00 amRNSGIANT Contract Win with Takaful Insurance
27th May 20157:00 amRNSInterim Results
18th May 20157:00 amRNSGIANT Contract Win with Brother Industries
12th May 20157:01 amRNSNotification of Interim Results Results
5th May 20157:01 amRNSNew GIANT Partnership
30th Apr 20157:00 amRNSTrading Update
24th Mar 20157:00 amRNSGIANT Contract Win
18th Mar 20157:00 amRNSAppointment of Joint Broker
6th Mar 201512:38 pmRNSResult of AGM
11th Feb 20157:00 amRNSDividend Declaration
10th Feb 20157:00 amRNSPosting of Annual Report
5th Feb 20157:00 amRNSPreliminary results
13th Jan 20157:00 amRNSNotification of Full Year Results
18th Nov 20147:00 amRNSCapital Markets Day
31st Oct 201410:43 amRNSNotification of Capital Markets Day
24th Oct 201412:26 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
13th Oct 20147:00 amRNSTrading Update
11th Sep 20147:30 amRNSDouble Awards
6th Aug 20141:30 pmRNSAIM Disclosure Update
24th Jun 20147:00 amRNSTechnology Alliance
23rd May 20144:25 pmRNSDirector's Share Dealing
21st May 20147:00 amRNSInterim Results
28th Apr 20147:00 amRNSTrading Update
17th Mar 20147:00 amRNSRevolution Analytics partnership
11th Mar 20147:00 amRNSFusionex secures further GIANT contract wins
10th Mar 20147:00 amRNSAGM Statement
11th Feb 20147:00 amRNSPosting of Annual Report
29th Jan 20147:00 amRNSFusionex secures first 'GIANT' contract win
28th Jan 20147:00 amRNSDividend Declaration
15th Jan 20147:00 amRNSPreliminary results
8th Jan 20147:00 amRNSNotification of Full Year Results
11th Dec 20137:00 amRNSProduct launch
6th Dec 20137:00 amRNSFusionex Wins Award
7th Oct 20137:00 amRNSTrading Update
13th Aug 20137:00 amRNSMicrosoft Business Intelligence Award
21st May 20137:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.